Read by QxMD icon Read

ADA diabetes 2015

Margaret A Powers
This address was delivered by Margaret A. Powers, PhD, RD, CDE, President, Health Care & Education, of the American Diabetes Association (ADA), at the ADA's 76th Scientific Sessions in New Orleans, LA, on 11 June 2016. Dr. Powers conducts research and has a clinical practice as a registered dietitian and diabetes educator at the International Diabetes Center at Park Nicollet in Minneapolis. Her research focuses on improving diabetes outcomes including factors that affect the clinical, psychosocial, and behavioral aspects of diabetes...
December 2016: Diabetes Care
J Quan, T K Li, H Pang, C H Choi, S C Siu, S Y Tang, N M Wat, J Woo, J M Johnston, G M Leung
AIMS: To estimate recent secular changes in the incidence and prevalence of diabetes and pre-diabetes among Hong Kong Chinese adults, and thus show possible future trends for developing mainland China. METHODS: Based on a complete census of the public sector health records of 6.4 million people from 2006 to 2014, diabetes cases were ascertained using different methods including the World Health Organization (WHO) 2011 guidelines (HbA1c , fasting plasma glucose and glucose tolerance test), American Diabetes Association (ADA) 2015 guidelines (plus random plasma glucose), and additionally recorded diagnosis codes and medication dispensation...
November 12, 2016: Diabetic Medicine: a Journal of the British Diabetic Association
Sijing Wu, Yujie Zhou, Yueping Li, Yuyang Liu, Dongmei Shi, Xiaoli Liu, Wei Liu, Yi Yu, Shuo Jia
BACKGROUND: Central hemodynamic indices have been demonstrated to correlate with coronary artery disease (CAD). However, in the context of type 2 diabetes mellitus (DM), this correlation has not been fully illustrated. Therefore, this study was employed to investigate the impact of DM on the correlation between aortic augmentation index and the severity of coronary artery disease. METHODS: In this study, we analyzed 197 patients who underwent coronary angiography at Anzhen Hospital from September 2015 to January 2016...
November 10, 2016: BMC Cardiovascular Disorders
E Hommel, S Schmidt, D Vistisen, K Neergaard, M Gribhild, T Almdal, K Nørgaard
AIMS: To test whether concomitant use of an automated bolus calculator for people with Type 1 diabetes carrying out advanced carbohydrate counting would induce further improvements in metabolic control. METHODS: We conducted a 12-month, randomized, parallel-group, open-label, single-centre, investigator-initiated clinical study. We enrolled advanced carbohydrate counting-naïve adults with Type 1 diabetes and HbA1c levels 64-100 mmol/mol (8.0-11.3%), who were receiving multiple daily insulin injection therapy...
October 20, 2016: Diabetic Medicine: a Journal of the British Diabetic Association
Valmore Bermúdez, Juan Salazar, Joselyn Rojas, María Calvo, Milagros Rojas, Mervin Chávez-Castillo, Roberto Añez, Mayela Cabrera
To determine the predictive power of various anthropometric indices for the identification of dysglycemic states in Maracaibo, Venezuela. A cross-sectional study with randomized, multi-staged sampling was realized in 2230 adult subjects of both genders who had their body mass index (BMI), waist circumference (WC) and waist-height ratio (WHR) determined. Diagnoses of type 2 diabetes mellitus (DM2) and impaired fasting glucose (IFG) were made following ADA 2015 criteria. ROC curves were used to evaluate the predictive power of each anthropometric parameter...
June 17, 2016: Journal of Community Health
Philipp E Scherer
The Banting Medal for Scientific Achievement is the highest scientific award of the American Diabetes Association (ADA). Given in memory of Sir Frederick Banting, one of the key investigators in the discovery of insulin, the Banting Medal is awarded annually for scientific excellence, recognizing significant long-term contributions to the understanding, treatment, or prevention of diabetes. Philipp E. Scherer, PhD, of the Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX, received the prestigious award at the ADA's 75th Scientific Sessions, 5-9 June 2015, in Boston, MA...
June 2016: Diabetes
J Cao, D Li, M Steffes, M D Bellin
In 2010, the American Diabetes Association (ADA) endorsed whole-blood HbA1c as a diagnostic test for diabetes mellitus, and selected 6.5% asthe diagnostic criterion for diabetes, and 5.7-6.4% as prediabetes [1]. Implementing this diagnostic standard requires the clinician to assume that HbA1c results are more-or-less equivalent regardless of the methodology employed; however, we were recently faced with the limitation of such an assumption at our institution. In early 2015, HbA1c values were simultaneously measured in five consecutive islet autotransplant recipients on no or low-dose insulin in both a research central laboratory [a secondary reference laboratory for the National Glycohemoglobin Standardization Program (NGSP)] using cation exchange high-performance liquid chromatography (HPLC) on Tosoh G8 (Tosoh Bioscience, Tokyo, Japan) and in our hospital's central chemistry laboratory using immunoassay (Dimension Vista 1500; Siemens Health Diagnostics, Erlangen, Germany)...
May 6, 2016: Diabetic Medicine: a Journal of the British Diabetic Association
François R Jornayvaz
The year 2015 was punctuated by numerous events in diabetology. First, the ADA/EASD guidelines have been updated. The pharmacological panel for type 2 diabetes treatment saw the arrival of different new molecules. Two new basal insulins were also approved. Also, cardiovascular safety trials have been published regarding recent antidiabetic drugs. A new insulin pump than can be coupled with a glucosensor was released. Finally, a new unexpected complication of SGLT2 inhibitors treatment was reported, the euglycemic keto-acidosis...
January 13, 2016: Revue Médicale Suisse
Linda M Delahanty
This article is adapted from the address Ms. Delahanty delivered as the recipient of the American Diabetes Association's (ADA) Outstanding Educator in Diabetes Award for 2015. She delivered the address in June 2015 at the Association's 75th Scientific Sessions in Boston, Mass. A webcast of this speech is available for viewing at the ADA website (
February 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
David G Marrero
This article is adapted from the address of the American Diabetes Association (ADA) President, Health Care and Education, given in June 2015 at the Association's 75th Scientific Sessions in Boston, Mass. A webcast of this speech is available for viewing at the ADA website (
February 2016: Diabetes Spectrum: a Publication of the American Diabetes Association
Bhavana Sosale, Aravind R Sosale, Anjana R Mohan, Prassanna M Kumar, Banshi Saboo, Sai Kandula
CONTEXT: Type 2 diabetes mellitus (T2DM) in young adults is increasing in India. Data on the prevalence of cardiovascular (CV) risk factors and complications associated with young-onset T2DM (YOD) at the time of diagnosis of diabetes are limited. This data can aid in aggressive diabetes management, CV risk reduction, and prevention of complications. AIM: To determine the prevalence of CV risk factors, micro and macrovascular complications in patients with newly diagnosed YOD...
January 2016: Indian Journal of Endocrinology and Metabolism
Sudhaa Sharma, Vishal R Tandon, Roshi, Annil Mahajan
INTRODUCTION: Oral antihyperglycaemic prescription trends keep on changing and thus the drug prescription trend study may prove to be powerful exploratory tool for health care providers. AIM: To investigate trends in prescriptions of oral antihyperglycaemic drugs (OHDs) among postmenopausal women suffering from T2DM in India and evaluate the rationality and adherence to ADA treatment guidelines. MATERIALS AND METHODS: An observational, cross-sectional descriptive prescription audit (n=500) was carried...
January 2016: Journal of Clinical and Diagnostic Research: JCDR
Hassan Tawfik, Zelaikha Bashwar, Amal Al-Ali, Mohamed Salem, Isameldin Abdelbagi
Incomplete vaccination for patients with type 2 diabetes attending non-communicable diseases (NCD) clinics is an issue that could affect patient's health and wellness negatively and puts patients at high risk of serious diseases. We aimed to improve physicians adherence to complete vaccination schedule for patients with type 2 diabetes attending NCD clinics in west bay health center according to American Diabetes Association (ADA) recommendation by 25% by January 2015. In the pre-intervention phase: the quality improvement team designed a checklist to collect the percentage of physician's adherence of prescription of the recommended vaccination for patients with type 2 diabetes...
2015: BMJ Quality Improvement Reports
Samuel Dagogo-Jack
This address was delivered by Samuel Dagogo-Jack, MD, President, Medicine & Science, of the American Diabetes Association (ADA), at the Association's 75th Scientific Sessions in Boston, MA, on 7 June 2015. Dr. Dagogo-Jack is a professor of medicine and the director of the Division of Endocrinology, Diabetes and Metabolism and the director of the Clinical Research Center at The University of Tennessee Health Science Center, Memphis, TN, where he holds the A.C. Mullins Endowed Chair in Translational Research...
January 2016: Diabetes Care
M Glessner
The 75th American Diabetes Association (ADA) Scientific Sessions, brought together experts in the diabetes research field to hear hundreds of oral presentations and thousands of poster presentations discussing novel research findings related to diabetes, obesity, fatty liver disease and related medical conditions. A significant number of presentations considered experimental and investigational therapeutic candidates that will potentially aid in the fight against diabetes, which continues to be on the increase worldwide...
June 2015: Drugs of Today
Yehuda Handelsman
OBJECTIVE: Following the first Food and Drug Administration (FDA) approval in 2013, sodium glucose cotransporter 2 (SGLT2) inhibitors have generated much interest among physicians treating patients with type 2 diabetes mellitus (T2DM). Here, the role in treatment with this drug class is considered in the context of T2DM treatment paradigms. METHODS: The clinical trials for the SGLT2 inhibitors are examined with a focus on canagliflozin, dapagliflozin, and empagliflozin...
September 2015: Endocrine Practice
Mahmoud Ibrahim, Megahed Abu Al Magd, Firas A Annabi, Samir Assaad-Khalil, Ebtesam M Ba-Essa, Ibtihal Fahdil, Sehnaz Karadeniz, Terry Meriden, Aly A Misha'l, Paolo Pozzilli, Samad Shera, Abraham Thomas, Suhad Bahijri, Jaakko Tuomilehto, Temel Yilmaz, Guillermo E Umpierrez
Since the first ADA working group report on the recommendations for management of diabetes during Ramadan in 2005 and our update in 2010, we received many inquiries asking for regular updates on information regarding education, nutritional habits and new oral and injectable agents that may be useful for the management of patients with diabetes during Ramadan. Patients can be stratified into their risk of hypoglycemia and/or complications prior to the start of the fasting period of Ramadan. Those at high risk of hypoglycemia and with multiple diabetic complications should be advised against prolonged fasting...
2015: BMJ Open Diabetes Research & Care
Jie-Qiong Li, Lan Tan, Hui-Fu Wang, Meng-Shan Tan, Lin Tan, Wei Xu, Qing-Fei Zhao, Jun Wang, Teng Jiang, Jin-Tai Yu
OBJECTIVE: We sought to identify the risk factors for predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD). METHODS: We searched 6 electronic databases for cohort studies published from January 1966 to March 2015. Eligible studies were required to be relevant to the subject and provide sufficient data for our needs. RESULTS: 60 cohort studies with 14,821 participants from 16 countries were included in the meta-analysis...
May 2016: Journal of Neurology, Neurosurgery, and Psychiatry
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"